Predictive variables for feelings of sadness and depression while working remotely in Brazil during the COVID-19 pandemic.

BACKGROUND: Remote work was evidenced in the pandemic and studies in this area increased. Most studies focus on professionals of companies or professors/students in the academic environment. At the same time, non-academic staff, that provide all the support required for the core activities of the institutions (research/teaching/extension activities) have been neglected. OBJECTIVE: This article aims to exploratory analyse which variables (interruptions when working remotely (1), health concerns (2) and fear of contracting coronavirus (3), anxiety and concern about professional career (4), frustration to have cancelled plans and missed opportunities (5) and gender (6)) can impact feelings of sadness and depression experienced by non-academic staff of a university working remotely. METHODS: Using a database on behaviour and feelings of non-academic staff from a Brazilian university working remotely during the COVID-19 pandemic, a binary logistic regression model was structured. In an exploratory manner, six independent variables (presented in the previous item) were analysed in terms of their ability to predict the dependent variable (feelings of sadness and depression). RESULTS: The results presented the prediction power of the independent variables for the dependent variable. The variables regarding concern with their health, increased anxiety and concern about their career presented Odds Ratios of 3.6 (1.4-8.5 -95% C.I.) and 3.3 (2.2-5.0 -95% C.I.), respectively, standing out from the other variables. CONCLUSIONS: These results focus on staff at one institution, but they can contribute to better understand feelings and behaviours experienced by professionals working remotely and provide information for debates on the field of COVID-19-related changes of work.

Moderating effect of OHS actions based on WHO recommendations to mitigate the effects of COVID-19 in multinational companies.

The objective of this study was to evaluate the moderating effect of Occupational Health and Safety actions based on the World Health Organization (WHO) recommendations to mitigate the negative effect of COVID-19 on the operational, logistical, marketing (OLMP), and health and safety performance (OHSP) of workers in multinational industries. The development of surveys in companies was the method adopted, which had confirmatory evaluations through Structural Equations Modelling (SEM). As a result, it was confirmed that this is one of the few scientific studies that expectedly validates that the COVID-19 pandemic has severely impacted operational, logistical, market, and Occupational Health and Safety (OHS) performance. This is also one of the few research projects to assess the moderating effect of OHS practices based on WHO to mitigate the effects of COVID-19. According to our findings, those practices were able to reduce by at least 50% the effect of the COVID-19 crisis on operational, logistical, and marketing performance. However, they minimize by only 1.8% the negative effects of health and safety performance for the worker, generating absenteeism increasingly due to physical and mental problems. This number could be higher if the social distance could be provided in public transportation and if employees were more aware of the risks of COVID-19 contamination during their social activities.

Impact of telemedicine on metabolic control and hospitalization of peritoneal dialysis patients during the COVID-19 pandemic: a national multicentric cohort study.

INTRODUCTION: The coronavirus-19 pandemic threatens the lives of all people, but results in higher mortality rates for patients with end-stage kidney disease (ESKD) including those on peritoneal dialysis (PD). Telemedicine was the main alternative to reduce exposure to the virus, but it was introduced in the Brazil without proper training. OBJECTIVE: To investigate the impact of telemedicine on metabolic control, peritonitis rates, and hospitalization in PD patients during the pandemic. METHODS: This was a retrospective multicenter cohort study. We included all adult patients on chronic PD from 9 clinics selected by convenience during the pandemic. The outcomes of interest were measured and compared between before and after switching to telemedicine using repeated measure analysis and multilevel Poisson regression. RESULTS: The study included 747 patients with a mean age of 59.7±16.6 years, of whom 53.7% were male and 40.8% had diabetes. Biochemical parameters including hemoglobin, potassium, phosphate, calcium, and urea serum levels did not change significantly after transition to telemedicine. There was no association between telemedicine and peritonitis rates. In contrast, hospitalization rates increased significantly in the telemedicine period. The incidence rate ratio (IRR) for hospitalization in the telemedicine period was 1.54 (95%CI 1.10-2.17; p 0.012) and 1.57 (95%CI 1.12-2.21; p 0.009) in the mixed-effects Poisson regression before and after adjustment for the presence of confounders. Admissions for hypervolemia and infections not related to PD doubled after transition to telemedicine. CONCLUSION: The implementation of telemedicine without proper training may lead to an increase in adverse events in PD patients.

Moderating effect of OHS actions based on WHO recommendations to mitigate the effects of COVID-19 in multinational companies

The objective of this study was to evaluate the moderating effect of Occupational Health and Safety actions based on the World Health Organization (WHO) recommendations to mitigate the negative effect of COVID-19 on the operational, logistical, marketing (OLMP), and health and safety performance (OHSP) of workers in multinational industries. The development of surveys in companies was the method adopted, which had confirmatory evaluations through Structural Equations Modelling (SEM). As a result, it was confirmed that this is one of the few scientific studies that expectedly validates that the COVID-19 pandemic has severely impacted operational, logistical, market, and Occupational Health and Safety (OHS) performance. This is also one of the few research projects to assess the moderating effect of OHS practices based on WHO to mitigate the effects of COVID-19. According to our findings, those practices were able to reduce by at least 50% the effect of the COVID-19 crisis on operational, logistical, and marketing performance. However, they minimize by only 1.8% the negative effects of health and safety performance for the worker, generating absenteeism increasingly due to physical and mental problems. This number could be higher if the social distance could be provided in public transportation and if employees were more aware of the risks of COVID-19 contamination during their social activities.

Recommendations from the Brazilian Society of Nephrology for approaching Covid-19 Diagnostic Testing in Dialysis Units

ABSTRACT The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19. RESUMO A pandemia da Covid-19 trouxe desafios ao sistema de saúde em diversas esferas: diagnóstico, tratamento e medidas para evitar a disseminação da doença. Com a maior disponibilização e variedades de testes diagnósticos, torna-se fundamental sua adequada interpretação. Este posicionamento pretende orientar unidades de diálise em relação ao uso de critérios clínicos e testes diagnósticos para a tomada de decisão referente à descontinuação do isolamento de pacientes com suspeita ou confirmação de Covid-19, assim como para o retorno às atividades laborais de colaboradores com suspeita ou confirmação de Covid-19.

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function

ABSTRACT Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment. RESUMO Em razão de resultados preliminares promissores, a hidroxicloroquina e a cloroquina têm sido discutidas como opção terapêutica para pacientes com Covid-19. Apesar da ausência de estudos robustos que evidenciem o benefício e justifiquem o uso de uma dessas drogas, a decisão final compete ao médico assistente, devendo ser individualizada e, sempre que possível, compartilhada. A presente nota pretende orientar o ajuste posológico dessas drogas no contexto da disfunção renal.

Recommendations from the Brazilian Society of Nephrology for approaching Covid-19 Diagnostic Testing in Dialysis Units.

The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function.

Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.

Good Practice Recommendations from the Brazilian Society of Nephrology to Dialysis Units Concerning the Pandemic of the New Coronavirus (Covid-19).

Dialysis units are environments potentially prone to the spread of Covid-19. Patients cannot suspend treatment, and they often have comorbidities, which assigns them a higher risk and worse prognosis. The Brazilian Society of Nephrology prepared this document of good practices, whose technical recommendations deal with general measures that can be implemented to reduce the risk of transmission and prevent the spread of the disease in the unit.